Phase Ia, first in human trial evaluating BI 1703880, a non-CDN STING agonist, in combination with ezabenlimab in solid tumors

Principal Investigator

Dr Eileen Parkes

Contact us

Email: orh-tr.earlyphasenurses@nhs.net

IRAS number

1006124